![Full central neurokinin-1 receptor blockade is required for efficacy in depression: evidence from orvepitant clinical studies]()
Full central neurokinin-1 receptor blockade is required for efficacy in depression: evidence from orvepitant clinical studiesRatti, E.; Bettica, P.; Alexander, R.; Archer, G.; Carpenter, D.; Evoniuk, G.; Gomeni, R.; Lawson, E.; Lopez, M.; Millns, H.; Rabiner, E. A.; Trist, D.; Trower, M.; Zamuner, S.; Krishnan, R.; Fava, M. · Journal of Psychopharmacology · 2013